Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dolastatin-10 in Advanced Hepatobiliary Cancer
NCT00003557Phase 2Completed
- Sponsor
- University of Chicago
- Start
- Jan 1999
- Primary completion
- Jun 2000
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dolastatin 10 in liver cancer, cholangiocarcinoma (CCA), gallbladder cancer, sponsored by University of Chicago. Started Jan 1999; status: completed.
02
Drugs
dolastatin 10
03
Conditions
liver cancercholangiocarcinoma (CCA)gallbladder cancer
Beyond the preview
Go deeper on NCT00003557.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003557.